Search for: "Eli Lilly "
Results 981 - 1000
of 2,131
Sorted by Relevance
|
Sort by Date
3 Apr 2007, 9:54 am
H&H's first such client against pharmaceutical giant Eli Lilly & Co. is the state of New Mexico, which claims it spent about $18 million on Zyprexa-related medical expenses between 1999 and 2005. [read post]
26 Mar 2010, 8:21 am
Eli Lilly, a majority of the en banc Federal Circuit decided to retain both traditional and Lilly written description as distinct requirements of patentability. [read post]
20 Mar 2013, 10:00 pm
., (S&N) Deferred Prosecution Agreement (DPA) for criminal FCPA violations, the Oracle SEC Complaint for books and records violations and the Eli Lilly and Company (Lilly) SEC Compliant for books and records violations. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen, ‘yes’ to… [read post]
11 Jun 2010, 12:55 pm
Another famous Qui-Tam lawsuit was filed by 6 employees of Eli Lilly & Company alleging that Zyprexa was marketed off-label for untested and unapproved uses. [read post]
9 Apr 2007, 7:30 am
Temple said the agency was "not particularly worried" about the drug.Also from this March 30 WSJ article, it seems as if Eli Lilly & Co. disputes this FDA action concerning pergolide products, including Permax:Eli Lilly & Co., which began marketing pergolide in the U.S. in 1989 and still sells it overseas, said it has no plans to pull it from foreign markets. [read post]
10 Apr 2015, 3:00 am
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
2 Apr 2016, 4:00 am
Migraines are the result of a hereditary neurological disorder which causes certain areas of the brain to become over-excited, creating the throbbing pain and increased sensitivity to lights, smells or sounds which characterize a migraine attack. [read post]
9 Feb 2019, 3:45 am
Bart van WezenbeekRelevant prior art may prove not to be useful as a starting point for an attack on inventive step if the prior art teaching is negated by later studies before the effective date of the patent claims. [read post]
7 Oct 2008, 7:02 pm
See the report by Zach Lowe in The American Lawyer. [read post]
10 Apr 2015, 3:00 am
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
14 Feb 2012, 8:25 am
Oral argument argued before the Eighth Circuit U.S. [read post]
3 Dec 2013, 3:10 am
Eli Lilly, of course, believes the cost of the test should be covered without restriction. [read post]
28 Dec 2015, 12:14 am
.* Mr Justice Carr tackles plausibility in Actavis v Lilly ADHD dispute (Part I)* Mr Justice Carr tackles plausibility in Actavis v Eli Lilly ADHD dispute (Part II)Annsley reports on the brand spanking new specialist Patents Court judge Mr Justice Carr’s decision in Actavis v Eli Lilly [2015] EWHC. [read post]
28 Nov 2019, 12:57 pm
In reply to the appeal, Eli Lilly has argued that it was incorrect for the EPO to apply the co-applicant to the patent. [read post]
21 Jul 2017, 3:14 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle. [read post]
14 Apr 2011, 11:38 am
Bucci orders Eli Lilly to remove her image, but, of course, the company refuses to do so. [read post]
13 Aug 2012, 4:30 am
Eli Lilly & Co., No. 11-2082, 2012 WL 3139233 (8th. [read post]
24 Aug 2012, 4:33 pm
” Eli Lilly & Co. v. [read post]
15 Jul 2010, 2:39 pm
Eli Lilly & Co., 192 Cal. [read post]
